Flublok Trivalent Northern Hemisphere Injection
Product Images NDC 49281-726

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Flublok Trivalent Northern Hemisphere (NDC 49281-726). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

Packaging label for Flublok Influenza Vaccine 45 mcg/0.5 mL, trivalent, 2026-2027 formula, distributed by Sanofi Pasteur Inc. The label indicates intramuscular use for individuals 9 years and older, supplied as 10 single-dose prefilled syringes of 0.5 mL each. It includes storage instructions, formulation details, and manufacturer information from Protein Sciences Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.